Retrieve available abstracts of 84 articles: HTML format
Single Articles
June 2025
LEE BY, Clemens DL, Maslesa-Galic S, Nava S, et al Adding Intranasal to Oral Administration of an Ultra-rapid Near Universal Drug
Regimen Accelerates Relapse-free Cure of Tuberculosis in Mice.
J Infect Dis. 2025 Jun 11:jiaf315. doi: 10.1093. PubMedAbstract available
KLEYNHANS L, Maasdorp E, Snyders CI, Seddon JA, et al Impact of puberty on immune responses to Mycobacterium tuberculosis in South
African adolescents.
J Infect Dis. 2025 Jun 2:jiaf293. doi: 10.1093. PubMedAbstract available
NGARA B, Flori L, van Wijk RC, Ernest JP, et al Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate
Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine
Models.
J Infect Dis. 2025;231:e901-e911. PubMedAbstract available
May 2025
VEEKEN LD, Schwalb A, Horton KC, Koesoemadinata RC, et al Mind the clinic-community gap: how concerned should we be about false positive
test results in mass tuberculosis screening?
J Infect Dis. 2025 May 23:jiaf268. doi: 10.1093. PubMedAbstract available
COLLINS JM, Bobosha K, Narayanan N, Gandhi NR, et al A plasma metabolic signature to diagnose pulmonary tuberculosis and monitor
treatment response.
J Infect Dis. 2025 May 8:jiaf240. doi: 10.1093. PubMedAbstract available
April 2025
ABDELGAWAD N, Wasserman S, Gausi K, Davis A, et al Population Pharmacokinetics of Rifampicin in Plasma and Cerebrospinal Fluid in
Adults With Tuberculosis Meningitis.
J Infect Dis. 2025 Apr 29:jiaf178. doi: 10.1093. PubMedAbstract available
FERNANDEZ MC, Peterson GJ, Le C, Skerrett SJ, et al Interferon Gamma Stimulation Fails to Restrict Mycobacterium tuberculosis Growth
in Human Monocyte-derived and Alveolar Macrophages.
J Infect Dis. 2025 Apr 26:jiaf220. doi: 10.1093. PubMedAbstract available
MACKAY EA, Platt G, Peloquin CA, Brooks MB, et al Impact of pharmacogenetics on pharmacokinetics of first-line anti-tuberculosis
drugs in the HIRIF trial.
J Infect Dis. 2025 Apr 17:jiaf195. doi: 10.1093. PubMedAbstract available
LOURENS R, Singh G, Arendse T, Thwaites G, et al Tuberculous meningitis across the lifespan.
J Infect Dis. 2025 Apr 8:jiaf181. doi: 10.1093. PubMedAbstract available
March 2025
PALADINO ME, Riva MA Comment On: Respiratory Isolation for Tuberculosis: A Historical Perspective.
J Infect Dis. 2025 Mar 26:jiaf161. doi: 10.1093. PubMed
THEODOROU DJ, Theodorou SJ Respiratory isolation of patients with tuberculosis: Is the way forward paved?
J Infect Dis. 2025 Mar 17:jiaf143. doi: 10.1093. PubMed
FOLKESSON E, Froberg G, Sundling C, Schon T, et al Improved detection of extrapulmonary and paucibacillary pulmonary tuberculosis by
Xpert MTB Host Response in a TB low endemic, high resource setting.
J Infect Dis. 2025 Mar 6:jiaf110. doi: 10.1093. PubMedAbstract available
February 2025
FU Y, Yang X, Ling Q, Huang Y, et al USP25 Promotes the Antimycobacterial Response of Macrophages Through Stabilizing
B-Raf and C-Raf.
J Infect Dis. 2025;231:366-377. PubMedAbstract available
NAN Y, Wang Y, Dong Y, Liu Y, et al Impact of Hypoxia-Inducible Factor-1alpha on Host Immune Metabolism and Tissue Damage
During Mycobacterium bovis Infection.
J Infect Dis. 2025;231:355-365. PubMedAbstract available
Correction to: Predictive Markers of Incident Tuberculosis in Close Contacts in
Brazil and India.
J Infect Dis. 2025 Feb 17:jiaf078. doi: 10.1093. PubMed
DEKKERS BGJ, Kerstjens HAM, Breisnes HW, Leeming DJ, et al Azithromycin as host-directed therapy for pulmonary tuberculosis - a randomized
pilot trial.
J Infect Dis. 2025 Feb 11:jiaf069. doi: 10.1093. PubMedAbstract available
HUGHES JA, Solans BP, Garcia-Prats AJ, Draper HR, et al Pharmacokinetics and safety of clofazimine in children with rifampicin-resistant
tuberculosis.
J Infect Dis. 2025 Feb 11:jiaf057. doi: 10.1093. PubMedAbstract available
KOLLMANN TR, Amenyogbe N, Schaltz-Buchholzer F, Baek O, et al Is systemic dissemination of BCG following neonatal vaccination required for
protection against M. tuberculosis?
J Infect Dis. 2025 Feb 6:jiaf051. doi: 10.1093. PubMedAbstract available
KATES OS, Shah M Integrating Ethics in Public Health Guideline Development: Case Study of
Guidelines on Respiratory Isolation for Persons With Tuberculosis in Community
Settings.
J Infect Dis. 2025;231:23-30. PubMedAbstract available
BONOMO EJ, Shah M Rights-Based Legal Considerations for Tuberculosis Isolation Practices in
Community Settings in the Postpandemic Era.
J Infect Dis. 2025;231:31-36. PubMedAbstract available
January 2025
STOLTZ A, Nathavitharana RR, de Kock E, Ueckermann V, et al Estimating the Early Transmission Inhibition of new treatment regimens for
drug-resistant tuberculosis.
J Infect Dis. 2025 Jan 9:jiaf005. doi: 10.1093. PubMedAbstract available
KOIRALA A, Smith K, Britton PN, Howard-Jones AR, et al Protracted Tuberculosis Outbreak in a Pasifika Diaspora in Western Sydney,
Australia: The Importance of Community Engagement.
J Infect Dis. 2025 Jan 9:jiae619. doi: 10.1093. PubMedAbstract available
NOGUEIRA BMF, Rangel F, Andrade AMS, Daniel EA, et al Predictive Markers of Incident Tuberculosis in Close Contacts in Brazil and
India.
J Infect Dis. 2025 Jan 7:jiae642. doi: 10.1093. PubMedAbstract available
December 2024
DAY CL, Njuguna IN, Cranmer LM, Whatney WE, et al Patterns and cofactors of polyfunctional mycobacteria-specific T cell response
restoration following 6-month antiretroviral treatment in children living with
HIV.
J Infect Dis. 2024 Dec 18:jiae630. doi: 10.1093. PubMedAbstract available
MENDELSOHN SC, Andrade BB, Mbandi SK, Andrade AMS, et al Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close
Contacts in Brazil.
J Infect Dis. 2024;230:e1355-e1365. PubMedAbstract available
SEARS CL, Shah M The Evolution of Tuberculosis Community Transmission Science and its Ethical and
Legal Constructs.
J Infect Dis. 2024 Dec 11:jiae612. doi: 10.1093. PubMed
November 2024
ZHAI PY, Zang X, Jiang T, Feng J, et al Health and Economic Impacts of Introducing Vaccae and Enhanced Drug-Resistant
Tuberculosis Management Strategies in China.
J Infect Dis. 2024 Nov 22:jiae590. doi: 10.1093. PubMedAbstract available
FERNANDES AI, Pinto AJ, Silverio D, Zedler U, et al Genetically diverse Mycobacterium tuberculosis isolates manipulate inflammasome
activation and IL-1beta secretion independently of macrophage metabolic rewiring.
J Infect Dis. 2024 Nov 21:jiae583. doi: 10.1093. PubMedAbstract available
RUELAS CASTILLO J, Guerrini V, Quijada D, Karanika S, et al Pharmacological inhibition of macrophage triglyceride biosynthesis pathways does
not improve Mycobacterium tuberculosis control in infected mice.
J Infect Dis. 2024 Nov 19:jiae577. doi: 10.1093. PubMedAbstract available
HUANG X, Wu J, Xu J, Wang H, et al Mycobacterium tuberculosis Antigen Rv1471 Induces Innate Immune Memory and
Adaptive Immunity against Infection.
J Infect Dis. 2024 Nov 14:jiae572. doi: 10.1093. PubMedAbstract available
October 2024
THOMPSON RR, Kim S, Pelissari DM, Harada LO, et al High mortality rates among individuals misdiagnosed with tuberculosis: a matched
retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
J Infect Dis. 2024 Oct 28:jiae531. doi: 10.1093. PubMedAbstract available
BI J, Guo Q, Gong Y, Chen X, et al Troglitazone reduces intracellular Mycobacterium tuberculosis survival via
macrophage autophagy through LKB1-AMPKalpha signaling.
J Infect Dis. 2024 Oct 25:jiae523. doi: 10.1093. PubMedAbstract available
RAJAGOPALAN S, Rourke AK, Asare E, Kohlerschmidt DJ, et al Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline,
Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium
tuberculosis Clinical Isolates.
J Infect Dis. 2024 Oct 16:jiae438. doi: 10.1093. PubMedAbstract available
SCHALTZ-BUCHHOLZER F, Nielsen S, Sorensen MK, Gomes GM, et al Maternal Bacille Calmette-Guerin Scars and Mortality Risk for Male and Female
Newborns: Observational Study From Guinea-Bissau.
J Infect Dis. 2024;230:995-1003. PubMedAbstract available
RIOPEL ND, Long R, Heffernan C, Tyrrell GJ, et al Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium
caprae Infections in Humans in Western Canada.
J Infect Dis. 2024;230:e789-e797. PubMedAbstract available
NATHAVITHARANA RR, Pearl A, Biewer A, Tzelios C, et al Assessing infectiousness and the impact of effective treatment to guide isolation
recommendations for people with pulmonary tuberculosis.
J Infect Dis. 2024 Oct 7:jiae482. doi: 10.1093. PubMedAbstract available
KARAKOUSIS PC, Mooney G Respiratory Isolation for Tuberculosis: A Historical Perspective.
J Infect Dis. 2024 Oct 7:jiae477. doi: 10.1093. PubMedAbstract available
September 2024
WALKER NF, Schutz C, Ward A, Barr D, et al Elevated Plasma Matrix Metalloproteinases Are Associated With Mycobacterium
tuberculosis Bloodstream Infection and Mortality in Human Immunodeficiency
Virus-Associated Tuberculosis.
J Infect Dis. 2024 Sep 2:jiae296. doi: 10.1093. PubMedAbstract available
August 2024
HORTON KC, McCaffrey T, Richards AS, Schwalb A, et al Estimating the impact of tuberculosis pathways on transmission - what is the gap
left by passive case-finding?
J Infect Dis. 2024 Aug 6:jiae390. doi: 10.1093. PubMedAbstract available
July 2024
CLARK RA, Sumner T, Weerasuriya CK, Bakker R, et al Estimating the Potential Public Health Value of BCG Revaccination.
J Infect Dis. 2024;230:e139-e143. PubMedAbstract available
GILS T, Hella J, Jacobs BKM, Sossen B, et al A prospective evaluation of the diagnostic accuracy of the point-of-care VISITECT
CD4 Advanced Disease test in seven countries.
J Infect Dis. 2024 Jul 24:jiae374. doi: 10.1093. PubMedAbstract available
RAJAMANICKAM A, Ann Daniel E, Dasan B, Thiruvengadam K, et al Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in
Household Contacts of TB Patients.
J Infect Dis. 2024 Jul 19:jiae365. doi: 10.1093. PubMedAbstract available
KARLSSON L, Ohrnberg I, Sayyab S, Martinez-Enguita D, et al A DNA Methylation Signature from Buccal Swabs to Identify Tuberculosis Infection.
J Infect Dis. 2024 Jul 4:jiae333. doi: 10.1093. PubMedAbstract available
June 2024
MUDDE SE, Ammerman NC, Ten Kate MT, Fotouhi N, et al Relative contributions of the novel diarylquinoline TBAJ-876 and its active
metabolite to the bactericidal activity in a murine model of tuberculosis.
J Infect Dis. 2024 Jun 28:jiae332. doi: 10.1093. PubMedAbstract available
SINHA P, Guerrant RL The Costly Vicious Cycle of Infections and Malnutrition.
J Infect Dis. 2024;229:1611-1613. PubMedAbstract available
May 2024
ARRIAGA MB, Amorim G, Figueiredo MC, Staats C, et al Effect of Smoking on Longitudinal Interferon-Upsilon Release Assay Results among Close
Contacts of People with Pulmonary Tuberculosis.
J Infect Dis. 2024 May 31:jiae285. doi: 10.1093. PubMedAbstract available
DIXIT A, Ektefaie Y, Kagal A, Freschi L, et al Drug resistance and epidemiological success of modern Mycobacterium tuberculosis
lineages in western India.
J Infect Dis. 2024 May 31:jiae240. doi: 10.1093. PubMedAbstract available
MEIWES L, Kontsevaya I, Chesov D, Kulcitkaia S, et al Whispers in the wind: Face mask sampling for Mycobacterium tuberculosis detection
in children with pulmonary tuberculosis.
J Infect Dis. 2024 May 27:jiae282. doi: 10.1093. PubMedAbstract available
SPRINGER YP, Tompkins ML, Newell K, Jones M, et al Characterizing the etiology of recurrent tuberculosis using whole genome
sequencing-Alaska, USA, 2008-2020.
J Infect Dis. 2024 May 24:jiae275. doi: 10.1093. PubMedAbstract available
ESPINOSA-PEREIRO J, Alagna R, Saluzzo F, Gonzalez-Moreno J, et al A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment
Efficacy Assessment in Tuberculosis Platform-Based Clinical Trials.
J Infect Dis. 2024;229:1584-1595. PubMedAbstract available
TAGAMI Y, Horita N, Kaneko M, Muraoka S, et al Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance:
Meta-analysis.
J Infect Dis. 2024;229:1481-1492. PubMedAbstract available
PETRILLO S, Di Prinzio RR, Quatrana A, Santoro A, et al Redox biomarkers in asymptomatic latent human tuberculosis: a comparison with
active disease.
J Infect Dis. 2024 May 9:jiae254. doi: 10.1093. PubMedAbstract available
BALASINGAM S, Dheda K, Fortune S, Gordon SB, et al Review of the current TB human infection studies for use in accelerating TB
vaccine development: A meeting report.
J Infect Dis. 2024 May 6:jiae238. doi: 10.1093. PubMedAbstract available
April 2024
MORO RN, Mehaffy C, De P, Phillips E, et al Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing
Flu-like Reactions During Treatment of Latent Tuberculosis Infection.
J Infect Dis. 2024 Apr 19:jiae180. doi: 10.1093. PubMedAbstract available
CROSS GB, O' Doherty J, Chang CC, Kelleher AD, et al Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2
Clinical Trials?
J Infect Dis. 2024;229:1229-1238. PubMedAbstract available
TAIT D, Diacon A, Borges AH, van Brakel E, et al Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in
adults successfully treated for drug-susceptible pulmonary TB: a phase 1
randomized trial.
J Infect Dis. 2024 Apr 1:jiae170. doi: 10.1093. PubMedAbstract available
March 2024
PATON NI, Gurumurthy M, Lu Q, Leek F, et al Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis:
proof-of-concept, partially-randomised, double-blind, placebo-controlled,
dose-escalation trial.
J Infect Dis. 2024 Mar 25:jiae104. doi: 10.1093. PubMedAbstract available
OLSSON O, Sokilde R, Tesfaye F, Karlson S, et al Tuberculosis disease is associated with elevated plasma ribonuclease activity in
antiretroviral treatment-naive people with HIV.
J Infect Dis. 2024 Mar 25:jiae143. doi: 10.1093. PubMedAbstract available
February 2024
XIAO G, Huang W, Zhong Y, Ou M, et al Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary
Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection.
J Infect Dis. 2024 Feb 27:jiae042. doi: 10.1093. PubMedAbstract available
OH IS, Kim JH, Huh K, Jang SH, et al Impact of National Public-Private Mix and Medical Expense Support Program for
Control Tuberculosis in South Korea: An Interrupted Time Series Analysis.
J Infect Dis. 2024 Feb 14:jiae059. doi: 10.1093. PubMedAbstract available
CHAUHAN KS, Dunlap MD, Akter S, Gupta A, et al NF-kappaB signaling deficiency in CD11c-expressing phagocytes mediates early
inflammatory responses and enhances Mycobacterium tuberculosis control.
J Infect Dis. 2024 Feb 7:jiae060. doi: 10.1093. PubMedAbstract available
January 2024
ZHENG Q, Li Z, Zhou Y, Li Y, et al Heparin-binding hemagglutinin of Mycobacterium tuberculosis inhibits autophagy
via TLR4 and drives M2 polarization in macrophages.
J Infect Dis. 2024 Jan 24:jiae030. doi: 10.1093. PubMedAbstract available
PEI X, Zhong T, Yang C, Sun L, et al Cost-Effectiveness of Community-Based Active Case Finding Strategy for
Tuberculosis: Evidence from Shenzhen, China.
J Infect Dis. 2024 Jan 23:jiae024. doi: 10.1093. PubMedAbstract available
RIDOLFI F, Amorim G, Peetluk LS, Haas DW, et al Prediction models for adverse drug reactions during tuberculosis treatment in
Brazil.
J Infect Dis. 2024 Jan 23:jiae025. doi: 10.1093. PubMedAbstract available
HUYNH J, Le NHT, Nguyen BHL, Hoang HT, et al The ability of a 3-gene host signature in blood to distinguish tuberculous
meningitis from other brain infections.
J Infect Dis. 2024 Jan 3:jiad606. doi: 10.1093. PubMedAbstract available
December 2023
ZAINABADI K, Vilbrun SC, Mathurin LD, Walsh KF, et al A bedaquiline, pyrazinamide, levofloxacin, linezolid, clofazimine second line
regimen for tuberculosis displays similar early bactericidal activity as the
standard rifampin based first line regimen.
J Infect Dis. 2023 Dec 7:jiad564. doi: 10.1093. PubMedAbstract available
November 2023
BLAZEVIC A, Edwards RL, Xia M, Eickhoff CS, et al Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus
Calmette-Guerin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
J Infect Dis. 2023 Nov 29:jiad441. doi: 10.1093. PubMedAbstract available
YUEN CM, Huang CC, Millones AK, Calderon RI, et al Utility of Mycobacterium tuberculosis genome sequencing snapshots to assess
transmission dynamics over time.
J Infect Dis. 2023 Nov 23:jiad515. doi: 10.1093. PubMedAbstract available
October 2023
SINGH B, Pahuja I, Yadav P, Shaji A, et al Adjunct therapy with all-trans-retinoic acid improves therapeutic efficacy
through immunomodulation while treating tuberculosis with antibiotics in a murine
model.
J Infect Dis. 2023 Oct 21:jiad460. doi: 10.1093. PubMedAbstract available
September 2023
ESCUDERO JN, Mecha J, Richardson BA, Maleche-Obimbo E, et al Impact of HIV and peripartum period on Mycobacterium tuberculosis infection
detection.
J Infect Dis. 2023 Sep 28:jiad416. doi: 10.1093. PubMedAbstract available
ABDELGAWAD N, Wasserman S, Abdelwahab MT, Davis A, et al Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid
among patients with tuberculosis meningitis.
J Infect Dis. 2023 Sep 22:jiad413. doi: 10.1093. PubMedAbstract available
NORE KG, Louet C, Bugge M, Gidon A, et al The Cyclooxygenase 2 inhibitor etoricoxib as adjunctive therapy in tuberculosis
impairs macrophage control of mycobacterial growth.
J Infect Dis. 2023 Sep 18:jiad390. doi: 10.1093. PubMedAbstract available
RASI V, Phelps KR, Paulson KR, Eickhoff CS, et al Homodimeric Granzyme A opsonizes Mycobacterium tuberculosis and inhibits its
intracellular growth in human monocytes via TLR4 and CD14.
J Infect Dis. 2023 Sep 6:jiad378. doi: 10.1093. PubMedAbstract available
August 2023
HILL PC, Cobelens F, Martinez L, Behr MA, et al An aspiration to radically shorten phase 3 TB vaccine trials.
J Infect Dis. 2023 Aug 22:jiad356. doi: 10.1093. PubMedAbstract available
MCSHANE H Improving TB vaccine trial efficiency: A tough nut to crack.
J Infect Dis. 2023 Aug 21:jiad360. doi: 10.1093. PubMed
June 2023
MAENETJE P, Baik Y, Schramm DB, Vangu MDW, et al Circulating biomarkers, FeNO, and lung function in patients with HIV and
tuberculosis.
J Infect Dis. 2023 Jun 30:jiad232. doi: 10.1093. PubMedAbstract available
SINGH DK, Bhaskar A, Pahuja I, Shaji A, et al Co-treatment with Clofazimine and Rapamycin eliminates drug-resistant
tuberculosis by inducing polyfunctional central memory T cell responses.
J Infect Dis. 2023 Jun 8:jiad214. doi: 10.1093. PubMedAbstract available
May 2023
CHEN S, Li C, Qin Z, Song L, et al Serum metabolomic profiles for distinguishing lung cancer from pulmonary
tuberculosis: identification of rapid and noninvasive biomarker.
J Infect Dis. 2023 May 29:jiad175. doi: 10.1093. PubMedAbstract available
RAMALINGAM S, Kumar A, Krug S, Mohan H, et al CRISPR correction of GBA mutation in hiPSCs restores normal function to Gaucher
macrophages and increases their susceptibility to Mycobacterium tuberculosis.
J Infect Dis. 2023 May 9:jiad141. doi: 10.1093. PubMedAbstract available
BORBORA SM, Satish BA, Sundar S, B M, et al Mycobacterium tuberculosis elevates SLIT2 expression within the host and
contributes to oxidative stress responses during infection.
J Infect Dis. 2023 May 9:jiad126. doi: 10.1093. PubMedAbstract available
April 2023
VAN DER HEIJDEN YF, Maruri F, Blackman A, Morrison R, et al Mycobacterium tuberculosis gene expression associated with fluoroquinolone
resistance and efflux pump inhibition.
J Infect Dis. 2023 Apr 20:jiad112. doi: 10.1093. PubMedAbstract available
ALEMNJI G, Mosha F, Maggiore P, Alexander H, et al Building Integrated Testing Programs for Infectious Diseases.
J Infect Dis. 2023 Apr 12:jiad103. doi: 10.1093. PubMedAbstract available
ROCCO JM, Laidlaw E, Galindo F, Anderson M, et al Mycobacterial Immune Reconstitution Inflammatory Syndrome in HIV is Associated
With Protein-Altering Variants in Hemophagocytic Lymphohistiocytosis-Related
Genes.
J Infect Dis. 2023 Apr 11:jiad059. doi: 10.1093. PubMedAbstract available
February 2023
SABO MC, Thuong NTT, Chang X, Ardiansyah E, et al MUC5AC genetic variation is associated with tuberculous meningitis CSF cytokine
responses and mortality.
J Infect Dis. 2023 Feb 24:jiad050. doi: 10.1093. PubMedAbstract available